Accepting new patients

Dr. Gordon Grado, MD

Radiation Oncology •  Male • Age 66

  22 Reviews
Dr. Grado

Yuma Oncology Center

1951 W 25th St Ste F Yuma, AZ 85364

Accepting new patients

Make an Appointment

(928) 317-9200

Dr. Gordon Grado, MD is a radiation oncology specialist in Yuma, AZ and has been practicing for 38 years. He graduated from Southern Illinois University School Of Medicine in 1977 and specializes in radiation oncology.


At a Glance

  • Recent Reviews Reviews made in the last 30 days. See reviews
  • Explains conditions well Patients said this doctor explains conditions well. See reviews
  • Hospital satisfaction Patients said they were highly satisfied at this doctor's hospital. See hospitals

Insurance Check

Search for your insurance provider

Dr. Grado accepts

Accepted insurance can change. Please double-check when making an appointment.

(928) 317-9200

Dr. Grado accepts the following insurance:

Aetna
Amerigroup (Wellpoint)
Medicaid
Assurant Health
Blue Cross Blue Shield
Blue Cross Blue Shield of Illinois
Blue Choice
CareOregon
Medicaid
CareSource
Medicaid
Cigna
Cigna PPO
Great West Healthcare-Cigna PPO
Community Health Choice
Medicaid
Coventry Health Care
Guardian
Health Net
Medicaid
Tricare
HealthPartners
HealthPlus
Medicaid
HealthPlus Amerigroup
Medicaid
Horizon Blue Cross Blue Shield of New Jersey
Medicaid
Humana
Choice Care PPO
Tricare
Husky Health
Medicaid
inHealth
Medicaid
INTotal Health
Medicaid
Medica
Medicaid
Medicaid
Midwest Health Plan
Medicaid
Molina Healthcare
Medicaid
MultiPlan
MultiPlan PPO
PHCS Network PPO
Peach State Health Plan
Medicaid
Principal Financial Group
Simply Healthcare Plans
Medicaid
Staywell (Wellcare)
Medicaid
Tricare
Ucare
UnitedHealthCare
Choice Plus POS
Medicaid
Navigate HMO
United Healthcare
Wellcare of Georgia
Medicaid
WellPoint

Background Check

Healthgrades does not collect malpractice claims information for Arizona
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Grado's experience treating your condition or procedure

Dr. Grado's Top Procedures and Conditions

Treatment Frequency
Cancer
very high
very high

Treatment Frequency

Dr. Grado treats Cancer more than 99% of his peers

Dr. Grado treats this condition more than 99% of his peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer

Dr. Grado's conditions and procedures:

  • Cancer
  • Cancer Treatment
  • Gynecologic Cancer
  • Prostate Brachytherapy
  • Skin Cancer Tumor Treatment
  • Tomotherapy

Dr. Grado's Reviews

Did you have an appointment with Dr. Grado?

Enter the Bills 4 Bills sweepstakes by leaving a review today

Terms and conditions

Likelihood to recommend Dr. Grado

4.5

Based on 22 reviews

5 Stars
86.36363636363636%
(19)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
13.636363636363637%
(3)

Leave a review

How likely are you to recommend
Dr. Grado?
(Select your rating)
Average Reported Wait Time
  • 10 – 15 minutes
Dr. Grado's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. Gordon Grado, MD
RecentHighestLowestMost Helpful
Reply
Dr Grado truly cares about he patients. He is “my” doctor who provides excellent care to me.
Was this helpful?
thumbs up icon option
thumbs down icon option
×Post a ResponseAre you Dr. Gordon Grado, MD?
Reply
Dr. Grado is through, knowledgeable, kind and compassionate. He stays abreast of his field of expertise and gets the best results for his patents.
Was this helpful?
thumbs up icon option
thumbs down icon option
×Post a ResponseAre you Dr. Gordon Grado, MD?
Reply
Excellent. Very professional, knowledgable, and thorough. Kent-Medical Professional
Was this helpful?
thumbs up icon option
thumbs down icon option
×Post a ResponseAre you Dr. Gordon Grado, MD?
Reply
Recommended 5 weeks radiation on my 64 year old father, with stage IV metastatic pancreatic cancer. Advised him to not do chemo during this time. Proceeded to schedule and start radiation without consulting my father's medical oncologist on the protocol. When we contacted our oncologist, he was shocked that Grado would recommend this treatment for a man in advanced stage cancer, and said would kill him not doing chemo. At best,inexcusably poor communication, at worst,unethical profit-seeking dr.
Was this helpful?
thumbs up icon option9
thumbs down icon option4
×Post a ResponseAre you Dr. Gordon Grado, MD?
Reply
He is the most compassionate, knowledgeable expert urologist! Mention his name to anyone in this field and they know who you are talking about! He did my brachytherapy 3 years ago and all is great!
Was this helpful?
thumbs up icon option7
thumbs down icon option
×Post a ResponseAre you Dr. Gordon Grado, MD?

Leave a review

How was your experience with Dr. Grado?

About Me

Care Philosophy

Our team of physicians, nurses, physicists and other personnel use a family centered approach in the care of cancer patients. We believe that a combination of experience and the latest technology sets us apart in being able to bring our patients the very best treatments available.

Specialties

  • Radiation Oncology

Board Certifications

  • Radiation Oncology
  • Therapeutic Radiology

Education

1981
Mayo Clinic Rochester
Residency Hospital
1978
University Chicago Hosps and Clins
Internship Hospital
1977
Southern Illinois University School Of Medicine
Medical School
1974
Eastern Illinois University
Undergraduate School
1981
1978
1977
1974

Languages

  • Spanish
  • English

Awards

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Grado treats patients.

Learn more

69% Patient experience rating, Equal to the national average

73% Patient experience rating, 4% higher than the national average

81% Patient experience rating, 12% higher than the national average

66% Patient experience rating, 3% lower than the national average

  • Patient Safety Excellence Award™ (2017)